切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2020, Vol. 17 ›› Issue (08) : 742 -747. doi: 10.3877/cma.j.issn.1672-6448.2020.08.006

所属专题: 文献

浅表器官超声影像学

桥本甲状腺炎合并良恶性结节的超声特征比较分析
侯怡卿1, 钱乐1, 杨志芳1, 张静雯1, 詹维伟,1()   
  1. 1. 200025 上海交通大学医学院附属瑞金医院超声诊断科
  • 收稿日期:2019-10-11 出版日期:2020-08-01
  • 通信作者: 詹维伟

Comparison of ultrasonographic characteristics of Hashimoto's thyroiditis with benign and malignant thyroid nodules

Hou Hou1, Qian Qian1, Yang Yang1, Zhang Zhang1, Zhan Zhan,1()   

  1. 1. Department of Ultrasonography, Ruijin Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai 200025, China
  • Received:2019-10-11 Published:2020-08-01
  • Corresponding author: Zhan Zhan
引用本文:

侯怡卿, 钱乐, 杨志芳, 张静雯, 詹维伟. 桥本甲状腺炎合并良恶性结节的超声特征比较分析[J]. 中华医学超声杂志(电子版), 2020, 17(08): 742-747.

Hou Hou, Qian Qian, Yang Yang, Zhang Zhang, Zhan Zhan. Comparison of ultrasonographic characteristics of Hashimoto's thyroiditis with benign and malignant thyroid nodules[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2020, 17(08): 742-747.

目的

探讨桥本甲状腺背景下伴有甲状腺恶性结节与伴有良性结节的腺体实质超声表现的不同,以鉴别桥本甲状腺炎合并结节的良恶性。

方法

回顾性选取2012年12月至2019年6月在上海瑞金医院行甲状腺手术、经病理确诊为桥本甲状腺炎且术前超声影像资料完整的患者456例。以术后病理结果为"金标准",将患者分为桥本甲状腺炎合并良性结节组175例;桥本甲状腺炎合并恶性结节组281例。对2组的甲状腺腺体大小、实质回声类型及实质血供进行比较分析。

结果

合并恶性结节的患者甲状腺两腺叶的前后径、左右径及峡部厚度均小于合并良性结节的患者(P均<0.01)。恶性结节组甲状腺实质最常见的回声类型为网格样改变(112/281,39.9%),而良性结节组最常见的为斑片状减低(80/175,45.7%)。良性结节组中斑片状减低型和结节样改变型的占比大于恶性结节组,差异均有统计学意义(χ2=3.986、4.100,P均<0.05),恶性结节组的网格样改变型占比大于良性结节组,且差异有统计学意义(χ2=4.818,P<0.05)。恶性结节组最常见的是血供类型为无明显改变或轻度增多型(180/281,64.1%),占比大于良性结节(64/175,36.6%);良性结节组最常见的血供类型为中度增多型(85/175,48.6%),占比大于恶性结节(61/281,21.7%);2组间比较差异均有统计学意义(χ2=32.748、35.753,P均<0.01)。

结论

形态较小、实质呈网格样改变、血供正常或轻度增加的桥本甲状腺炎腺体背景更易伴发恶性结节,腺体的超声影像学评估有助于桥本甲状腺炎合并结节的良恶性鉴别。

Objective

To compare the ultrasonographic features of thyroid parenchyma of patients with Hashimoto thyroiditis (HT) concomitant with benign and malignant thyroid nodules to investigate if features of thyroid parenchyma can help diagnose malignant nodules in patients with HT.

Methods

A total of 456 patients who had HT concomitant with thyroid nodules and underwent thyroidectomy at Shanghai Ruijin Hospital between December 2012 and June 2019 were retrospectively included. The patients were divided into two groups: HT with benign nodules (n=175) and HT with malignant nodules (n=281). The size of the thyroid gland and echo type and blood supply of thyroid parenchyma were evaluated and compared between the two groups.

Results

The anteroposterior diameter, transverse diameter, longitudinal diameter, and isthmus thickness of thyroid lobes in patients with malignant nodules were smaller than those in patients with benign nodules (P<0.01). The most common echo type of thyroid parenchyma in the malignant group was grid like changes (112/281, 39.9%), while the most common type in the benign group was micronodular hypoechoic changes (80/175, 45.7%). The percentages of patients with micronodular hypoechoic changes and nodular changes in the benign group were significantly higher than those in the malignant group (χ2=3.986 and 4.100, P<0.05). The percentage of patients with grid like changes in the malignant group was significantly higher than that in the benign group (χ2=4.818, P<0.05). The most common type of blood supply in the malignant group was normal or slight increase of blood supply (180/281, 64.1%), which was significantly more frequent than that in the benign group (64/175, 36.6%; χ2=32.748, P<0.01). In the benign group, moderately increased blood supply of the parenchyma is the most common type (85/175, 48.6%), which was significantly more frequent than that in the malignant group (61/281, 21.7%; χ2=35.753, P<0.01).

Conclusion

Evaluating the sonographic features of thyroid parenchyma is helpful to differentiate benign and malignant nodules in patients with HT. A smaller size of the thyroid gland and normal or slightly increased blood supply with grid like changes of the parenchyma often indicate a greater chance of having malignant nodules.

图1 甲状腺实质回声分型超声图像。图a为无明显改变型;图b为弥漫性减低型;图c为斑片状减低型;图d为网格样改变型;图e为结节样改变型
图2 甲状腺实质血供分型超声图像。图a为无明显改变或轻度增加型;图b为中等程度增多型;图c为明显增多型;图d为明显减少型
表1 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺径线大小比较[mm,MQR)]
表2 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺实质回声比较[例(%)]
表3 桥本甲状腺合并恶性结节组与合并良性结节组的甲状腺实质血供比较[例(%)]
1
Ragusa F, Fallahi P, Elia G, et al. Hashimotos' thyroiditis: Epidemiology, pathogenesis, clinic and therapy[J]. Best Pract Res Clin Endocrinol Metab, 2019, 33(6): 101367.
2
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
3
Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland[J]. AMA Arch Surg, 1955, 70(2): 291-297.
4
Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement[J]. Radiology, 2005, 237(3): 794-800.
5
Gul K, Dirikoc A, Kiyak G, et al. The association between thyroid carcinoma and Hashimoto's thyroiditis: the ultrasonographic and histopathologic characteristics of malignant nodules[J]. Thyroid, 2010, 20(8): 873-878.
6
Singh B, Shaha AR, Trivedi H, et al. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome[J]. Surgery, 1999, 126(6): 1070-1077.
7
Resende de Paiva C, Grønhøj C, Feldt-Rasmussen U, et al. Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients[J]. Front Oncol, 2017, 7: 53.
8
Lai X, Xia Y, Zhang B, et al. A meta-analysis of Hashimoto's thyroiditis and papillary thyroid carcinoma risk[J]. Oncotarget, 2017, 8(37): 62414-62424.
9
杨志芳,詹维伟,周建桥. 超声对桥本甲状腺炎甲状腺微小乳头状癌的诊断价值[J/CD]. 中华医学超声杂志(电子版), 2014, 11(10): 840-844.
10
黄伟钦,薛恩生,林礼务, 等. 桥本甲状腺炎背景下甲状腺癌的超声表现探讨[J/CD]. 中华医学超声杂志(电子版), 2009, 6(3): 531-538.
11
Kim HG, Kim EK, Han KH, et al. Pathologic spectrum of lymphocytic infiltration and recurrence of papillary thyroid carcinoma[J]. Yonsei Med J, 2014, 55(4): 879-885.
12
Stuart A. The changing scene in Hashimoto's disease: a review[J]. Med Hypotheses, 2011, 77(3): 424-426.
13
Fiore E, Rago T, Latrofa F, et al. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine[J]. Endocr Relat Cancer, 2011, 18(4): 429-437.
14
Silva de Morais N, Stuart J, Guan H, et al. The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer[J]. J Endocr Soc, 2019, 3(4): 791-800.
15
Kim ES, Lim DJ, Baek KH, et al. Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules[J]. Thyroid, 2010, 20(8): 885-891.
16
Kang DY, Kim KH, Kim JM, et al. High prevalence of RET, RAS, and ERK expression in Hashimoto's thyroiditis and in papillary thyroid carcinoma in the Korean population[J]. Thyroid, 2007, 17(11): 1031-1038.
17
Willms A, Bieler D, Wieler H, et al. Correlation between sonography and antibody activity in patients with Hashimoto thyroiditis[J]. J Ultrasound Med, 2013, 32(11): 1979-1986.
18
Guarino V, Castellone MD, Avilla E, et al. Thyroid cancer and inflammation[J]. Mol Cell Endocrinol, 2010, 321(1): 94-102.
19
Radetti G, Loche S, D'Antonio V, et al. Influence of Hashimoto Thyroiditis on the Development of Thyroid Nodules and Cancer in Children and Adolescents[J]. J Endocr Soc, 2019, 3(3): 607-616.
20
Frates MC, Benson CB, Doubilet PM, et al. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules?[J]. J Ultrasound Med, 2003, 22(2): 127-134.
21
Sostre S, Reyes MM. Sonographic diagnosis and grading of Hashimoto's thyroiditis[J]. J Endocrinol Invest, 1991, 14(2): 115-121.
22
Latina A, Gullo D, Trimarchi F, et al. Hashimoto's thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer[J]. PLoS One, 2013, 8(3): e55450.
[1] 魏淑婕, 惠品晶, 丁亚芳, 张白, 颜燕红, 周鹏, 黄亚波. 单侧颈内动脉闭塞患者行颞浅动脉-大脑中动脉搭桥术的脑血流动力学评估[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1046-1055.
[2] 张璇, 马宇童, 苗玉倩, 张云, 吴士文, 党晓楚, 陈颖颖, 钟兆明, 王雪娟, 胡淼, 孙岩峰, 马秀珠, 吕发勤, 寇海燕. 超声对Duchenne肌营养不良儿童膈肌功能的评价[J]. 中华医学超声杂志(电子版), 2023, 20(10): 1068-1073.
[3] 丁雷, 罗文, 杨晓, 庞丽娜, 张佩蒂, 刘海静, 袁佳妮, 刘瑾. 高帧频超声造影在评价C-TIRADS 4-5类甲状腺结节成像特征中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(09): 887-894.
[4] 张茜, 陈佳慧, 高雪萌, 赵傲雪, 黄瑛. 基于高帧频超声造影的影像组学特征鉴别诊断甲状腺结节良恶性的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 895-903.
[5] 朱连华, 费翔, 韩鹏, 姜波, 李楠, 罗渝昆. 高帧频超声造影在胆囊息肉样病变中的鉴别诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 904-910.
[6] 张梅芳, 谭莹, 朱巧珍, 温昕, 袁鹰, 秦越, 郭洪波, 侯伶秀, 黄文兰, 彭桂艳, 李胜利. 早孕期胎儿头臀长正中矢状切面超声图像的人工智能质控研究[J]. 中华医学超声杂志(电子版), 2023, 20(09): 945-950.
[7] 陈舜, 薛恩生, 叶琴. PDCA在持续改进超声危急值管理制度中的价值[J]. 中华医学超声杂志(电子版), 2023, 20(09): 974-978.
[8] 周钰菡, 肖欢, 唐毅, 杨春江, 周娟, 朱丽容, 徐娟, 牟芳婷. 超声对儿童髋关节暂时性滑膜炎的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(08): 795-800.
[9] 刘欢颜, 华扬, 贾凌云, 赵新宇, 刘蓓蓓. 颈内动脉闭塞病变管腔结构和血流动力学特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 809-815.
[10] 郏亚平, 曾书娥. 含鳞状细胞癌成分的乳腺化生性癌的超声与病理特征分析[J]. 中华医学超声杂志(电子版), 2023, 20(08): 844-848.
[11] 张丽丽, 陈莉, 余美琴, 聂小艳, 王婧玲, 刘婷. PDCA循环法在超声浅表器官亚专科建设中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(07): 717-721.
[12] 李卫民, 陈军民, 黄艳丽, 范晓芳, 韩文, 贾磊, 张俊超, 瞿辰. 基于中国甲状腺超声报告与数据系统分析超声在不同大小甲状腺结节中的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(07): 743-748.
[13] 罗刚, 泮思林, 陈涛涛, 许茜, 纪志娴, 王思宝, 孙玲玉. 超声心动图在胎儿心脏介入治疗室间隔完整的肺动脉闭锁中的应用[J]. 中华医学超声杂志(电子版), 2023, 20(06): 605-609.
[14] 黄佳, 石华, 张玉国, 胡佳琪, 陈茜. 胎儿左头臂静脉正常与异常超声图像特征及其临床意义[J]. 中华医学超声杂志(电子版), 2023, 20(06): 610-617.
[15] 袁泽, 庄丽. 超声检测胎儿脐动脉和大脑中动脉血流对胎儿宫内窘迫的诊断价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 618-621.
阅读次数
全文


摘要